Glucosamine and warfarin alert
Glucosamine is widely used for the symptoms of osteoarthritis. Recent reports have suggested that it may interact with warfarin and thus make blood less likely to clot. The mechanism for this is uncertain. However, Arthritis Australia recommends that patients on warfarin who are starting or stopping glucosamine should have their INR (blood clotting) checked regularly for the first month. Patients who are on stable doses of both are unlikely to have problems.
Prof. Graeme Jones
Arthritis Australia Medical Director
A new pathway for Arthritis: Arthritis Australia launches National Strategic Action Plan
The Action Plan outlines key priorities for preventing arthritis, investing in research and improving treatment and support for people living with the condition. Four million...
Labor commits $2.1 million to fund arthritis educators
Arthritis Australia welcomes the commitment by the Australian Labor Party, if elected, to provide $2.1 million to fund arthritis educators. The commitment is set out...
$120,000 scholarship to combat ‘serious shortage’ of paediatric rheumatologists in Australia so kids with arthritis get the care they need
On offer is a two-year scholarship to support paediatricians and paediatric trainees interested in training in paediatric rheumatology. The scholarship will be equivalent to the...
Sign up to Arthritis Insights
Regular updates, news and research findings delivered to your inbox: